CompletedPhase 2NCT00202397

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

Studying Spinocerebellar ataxia type 40

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: S. Andrea Hospital
Principal Investigator: Marco Salvetti, Assoc. Prof
S.Andrea Hospital, University of Rome "La Sapienza"
Intervention: Riluzole(drug)
Enrollment: 40 enrolled
Eligibility: 18-80 years · All sexes
Timeline: 2005 – 2008

Study locations (1)

S.Andrea Hospital - University of Rome "La Sapienza", Rome, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00202397 on ClinicalTrials.gov

← Back to all trials